Compare ACLX & TDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACLX | TDS |
|---|---|---|
| Founded | 2015 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.5B |
| IPO Year | 2022 | N/A |
| Metric | ACLX | TDS |
|---|---|---|
| Price | $114.88 | $45.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $115.85 | $53.33 |
| AVG Volume (30 Days) | ★ 1.0M | 782.9K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.35% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,286,000.00 | N/A |
| Revenue This Year | $411.22 | $4.05 |
| Revenue Next Year | $138.37 | $1.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $47.86 | $31.07 |
| 52 Week High | $114.94 | $47.80 |
| Indicator | ACLX | TDS |
|---|---|---|
| Relative Strength Index (RSI) | 80.84 | 58.93 |
| Support Level | $66.06 | $43.02 |
| Resistance Level | N/A | $47.43 |
| Average True Range (ATR) | 0.16 | 1.11 |
| MACD | -1.09 | 0.32 |
| Stochastic Oscillator | 89.36 | 92.38 |
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.